Abstract
Pazopanib is multitargeted tyrosine kinase inhibitor used for the treatment of metastatic renal cell carcinoma. Hair colour change is a common side effect of pazopanib therapy which usually develops gradually...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have